Conversations About Opioids: Impact of the Opioid Overdose Epidemic on Social Interactions for People Who Live With Chronic Pain

Abstract

The objective of this study was to understand the impact of the opioid overdose epidemic on the social lives of people suffering from chronic pain, focusing on interactions within their personal and professional circles. The study was based on 22 in-depth interviews with people living with chronic pain in Canada. Using thematic analysis, we documented three main impacts of the opioid overdose epidemic: (a) increased worries of people in pain and their families regarding the dangers of opioids; (b) prejudices, stigma, and discrimination faced during conversations about opioids; and (c) stigma management attempts, which include self-advocacy and concealment of opioid use. This study represents important knowledge advancement on how people manage stigma and communicate about chronic disease during everyday life interactions. By showing negative effects of the epidemic’s media coverage on the social experiences of people with chronic pain, we underscore needs for destigmatizing approaches in public communication regarding opioids.

Keywords

chronic pain opioids social interactions illness experience stigma semi-structured interviews sociology Canada qualitative

Get full access to this article

View all access options for this article.

References

Antoniou

Ala-Leppilampi

Shearer

Parsons

J. A.

Tadrous

Gomes

(2019). “Like being put on an ice floe and shoved away”: A qualitative study of the impacts of opioid-related policy changes on people who take opioids. International Journal of Drug Policy, 66, 15–22. https://doi.org/10.1016/j.drugpo.2019.01.015

Baszanger

(1989). Pain: Its experience and treatments. Social Science & Medicine, 29(3), 425–434. https://doi.org/10.1016/0277-9536(89)90291-8

Berends

Johnston

(2005). Using multiple coders to enhance qualitative analysis: The case of interviews with consumers of drug treatment. Addiction Research & Theory, 13(4), 373–381. https://doi.org/10.1080/16066350500102237

Boulton

(2019). Nothing and everything: Fibromyalgia as a diagnosis of exclusion and inclusion. Qualitative Health Research, 29(6), 809–819. https://doi.org/10.1177/1049732318804509

Breivik

Collett

Ventafridda

Cohen

Gallacher

(2006). Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain, 10(4), 287–333. https://doi.org/10.1016/j.ejpain.2005.06.009

Buchman

D. Z.

Illes

(2016). You present like a drug addict: Patient and clinician perspectives on trust and trustworthiness in chronic pain management. Pain Medicine, 17(8), 1394–1406. https://doi.org/10.1093/pm/pnv083

Buchman

D. Z.

Leece

Orkin

(2017). The epidemic as stigma: The bioethics of opioids. The Journal of Law, Medicine & Ethics, 45(4), 607–620. https://doi.org/10.1177/1073110517750600

Bury

(1982). Chronic illness as biographical disruption. Sociology of Health & Illness, 4(2), 167–182. https://doi.org/10.1111/1467-9566.ep11339939

Busse

J. W.

Craigie

Juurlink

D. N.

Buckley

D. N.

Wang

Couban

R. J.

Agoritsas

Akl

E. A.

Carrasco-Labra

Cooper

Cull

da Costa

B. R.

Frank

J. W.

Grant

Iorio

Persaud

Stern

Tugwell

Vandvik

P. O.

Guyatt

G. H.

(2017). Guideline for opioid therapy and chronic noncancer pain. Canadian Medical Association Journal, 189(18), Article E659–E666. https://doi.org/10.1503/cmaj.170363

10.

Canadian Pain Task Force. (2019). Chronic pain in Canada: Laying a foundation for action. Health Canada.

11.

Carr

D. B.

(2016). Patients with pain need less stigma, not more. Pain Medicine, 17(8), 1391–1393. https://doi.org/10.1093/pm/pnw158

12.

Carroll

J. J.

Marshall

B. D. L.

Rich

J. D.

Green

T. C.

(2017). Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. International Journal of Drug Policy, 46, 136–145. https://doi.org/10.1016/j.drugpo.2017.05.023

13.

Centers for Disease Control and Prevention. (2011). Policy impact: Prescription painkiller overdoses.

14.

Centers for Disease Control and Prevention. (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. Recomendations and Reports, U.S. Department of Health and Human Services.

15.

Charmaz

(1983). Loss of self: A fundamental form of suffering in the chronically ill. Sociology of Health & Illness, 5(2), 168–195. https://doi.org/10.1111/1467-9566.ep10491512

16.

Chou

Turner

J. A.

Devine

E. B.

Hansen

R. N.

Sullivan

S. D.

Blazina

Dana

Bougatsos

Deyo

R. A.

(2015). The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Annals of Internal Medicine, 162(4), 276–286. https://doi.org/10.7326/M14-2559

17.

Conrad

(1990). Qualitative research on chronic illness: A commentary on method and conceptual development. Social Science & Medicine, 30(11), 1257–1263. https://doi.org/10.1016/0277-9536(90)90266-U

18.

Corbin

Strauss

(1985). Managing chronic illness at home: Three lines of work. Qualitative Sociology, 8(3), 224–247. https://doi.org/10.1007/BF00989485

19.

Corbin

Strauss

A. L.

(2015). Basics of qualitative research: Techniques and procedures for developing grounded theory (4th ed.). SAGE.

20.

Crabtree

Lostchuck

Chong

Shapiro

Slaunwhite

(2020). Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada. Canadian Medical Association Journal, 192(34), Article E967–E972. https://doi.org/10.1503/cmaj.200191

21.

Craig

K. D.

Holmes

Hudspith

Moor

Moosa-Mitha

Varcoe

Wallace

(2020). Pain in persons who are marginalized by social conditions. PAIN, 161(2), 261–265. https://doi.org/10.1097/j.pain.0000000000001719

22.

Creswell

J. W.

Plano Clark

V. L.

(2018). Designing and conducting mixed methods research (3rd ed.). SAGE.

23.

Cummings

E. C.

van Schalkwyk

G. I.

Grunschel

B. D.

Snyder

M. K.

Davidson

(2017). Self-efficacy and paradoxical dependence in chronic back pain: A qualitative analysis. Chronic Illness, 13(4), 251–261. https://doi.org/10.1177/1742395317690033

24.

Dassieu

Heino

Develay

É.

Kaboré

J.-L.

Pagé

M. G.

Moor

Hudspith

Choinière

(2021). “They think you’re trying to get the drug”: Qualitative investigation of chronic pain patients’ health care experiences during the opioid overdose epidemic in Canada. Canadian Journal of Pain. https://doi.org/10.1080/24740527.2021.1881886

25.

Dassieu

Kaboré

J.-L.

Choinière

Arruda

Roy

. (2019). Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis. International Journal of Drug Policy, 71, 150–156. https://doi.org/10.1016/j.drugpo.2019.03.023

26.

Dassieu

Kaboré

J.-L.

Choinière

Arruda

Roy

. (2020). Painful lives: Chronic pain experience among people who use illicit drugs in Montreal (Canada). Social Science & Medicine, 246, 112734. https://doi.org/10.1016/j.socscimed.2019.112734

27.

De Ruddere

Craig

K. D

. (2016). Understanding stigma and chronic pain: A-state-of-the-art review. Pain, 157(8), 1607–1610. https://doi.org/10.1097/j.pain.0000000000000512

28.

Eaves

E. R.

(2015). “Just Advil”: Harm reduction and identity construction in the consumption of over-the-counter medication for chronic pain. Social Science & Medicine, 146, 147–154. https://doi.org/10.1016/j.socscimed.2015.10.033

29.

Eaves

E. R.

Nichter

Ritenbaugh

Sutherland

Dworkin

S. F.

(2015). Works of illness and the challenges of social risk and the specter of pain in the lived experience of TMD. Medical Anthropology Quarterly, 29(2), 157–177. https://doi.org/10.1111/maq.12146

30.

Fischer

Rehm

Tyndall

(2016). Effective Canadian policy to reduce harms from prescription opioids: Learning from past failures. CMAJ, 188(17–18), 1240–1244. https://doi.org/10.1503/cmaj.160356

31.

Fraser

Pienaar

Dilkes-Frayne

Moore

Kokanovic

Treloar

Dunlop

(2017). Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis. The International Journal on Drug Policy, 44, 192–201. https://doi.org/10.1016/j.drugpo.2017.02.005

32.

Goffman

(1963). Stigma: Notes on the management of spoiled identity. Prentice Hall.

33.

Goldberg

D. S.

(2017). Pain, objectivity and history: Understanding pain stigma. Medical Humanities, 43(4), 238–243. https://doi.org/10.1136/medhum-2016-011133

34.

Goldberg

D. S.

McGee

S. J.

(2011). Pain as a global public health priority. BMC Public Health, 11, 770. https://doi.org/10.1186/1471-2458-11-770

35.

Good

B. J.

(1992). A body in pain: The making of a world of chronic pain. In DelVecchio Good

M.-J. D.

Brodwin

P. E.

Good

B. J.

Kleinman

(Eds.), Pain as human experience: An anthropological perspective (pp. 100–137). University of California Press.

36.

Jackson

J. E.

(2005). Stigma, liminality, and chronic pain: Mind–body borderlands. American Ethnologist, 32(3), 332–353. https://doi.org/10.1525/ae.2005.32.3.332

37.

Joachim

Acorn

(2000). Stigma of visible and invisible chronic conditions. Journal of Advanced Nursing, 32(1), 243–248. https://doi.org/10.1046/j.1365-2648.2000.01466.x

38.

Kaboré

J.-L.

Pagé

M. G.

Dassieu

Roy

Laliberté

Parent

Martel

M. O.

Choinière

(2018). Patients’ opinions and concerns about the opioid crisis in Quebec: Preliminary findings. Canadian Journal of Pain, 2(1), Article A98.

39.

Knight

K. R.

Kushel

Chang

J. S.

Zamora

Ceasar

Hurstak

Miaskowski

(2017). Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use. Social Science & Medicine, 186, 87–95. https://doi.org/10.1016/j.socscimed.2017.05.043

40.

Kornfield

Rowland

Bernstein

Barrett

(2020). Purdue Pharma agrees to plead guilty to federal criminal charges in settlement over opioid crisis. Washington Post. https://www.washingtonpost.com/national-security/2020/10/21/purdue-pharma-charges/

41.

Lagisetty

P. A.

Healy

Garpestad

Jannausch

Tipirneni

Bohnert

A. S. B.

(2019). Access to primary care clinics for patients with chronic pain receiving opioids. JAMA Network Open, 2(7), Article e196928. https://doi.org/10.1001/jamanetworkopen.2019.6928

42.

Lillrank

(2003). Back pain and the resolution of diagnostic uncertainty in illness narratives. Social Science & Medicine, 57(6), 1045–1054. https://doi.org/10.1016/S0277-9536(02)00479-3

43.

Link

B. G.

Phelan

J. C.

(2001). Conceptualizing stigma. Annual Review of Sociology, 27(1), 363–385. https://doi.org/10.1146/annurev.soc.27.1.363

44.

Lonardi

(2007). The passing dilemma in socially invisible diseases: Narratives on chronic headache. Social Science & Medicine, 65(8), 1619–1629. https://doi.org/10.1016/j.socscimed.2007.07.007

45.

Mayer

Boyd

Collins

Kennedy

M. C.

Fairbairn

McNeil

(2018). Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada. Drug and Alcohol Dependence, 193, 69–74. https://doi.org/10.1016/j.drugalcdep.2018.09.006

46.

McCradden

M. D.

Vasileva

Orchanian-Cheff

Buchman

D. Z.

(2019). Ambiguous identities of drugs and people: A scoping review of opioid-related stigma. International Journal of Drug Policy, 74, 205–215. https://doi.org/10.1016/j.drugpo.2019.10.005

47.

Mellado

B. H.

Falcone

A. C. M.

Poli-Neto

O. B.

Rosa

Silva

J. C.

Nogueira

A. A.

Candido-Dos-Reis

F. J.

(2016). Social isolation in women with endometriosis and chronic pelvic pain. International Journal of Gynaecology and Obstetrics, 133(2), 199–201. https://doi.org/10.1016/j.ijgo.2015.08.024

48.

Merskey

Bogduk

(1994). Classification of chronic pain (2nd ed.). IASP Press.

49.

Miles

M. B.

Huberman

A. M.

Saldana

(2014). Qualitative data analysis. SAGE.

50.

Paquette

C. E.

Syvertsen

J. L.

Pollini

R. A.

(2018). Stigma at every turn: Health services experiences among people who inject drugs. The International Journal on Drug Policy, 57, 104–110. https://doi.org/10.1016/j.drugpo.2018.04.004

51.

Paul-Savoie

Bourgault

Potvin

Gosselin

Lafrenaye

(2018). The impact of pain invisibility on patient-centered care and empathetic attitude in chronic pain management. Pain Research & Management, 2018, Article 6375713. https://doi.org/10.1155/2018/6375713

52.

Pierret

(2003). The illness experience: State of knowledge and perspectives for research. Sociology of Health & Illness, 25(3), 4–22. https://doi.org/10.1111/1467-9566.t01-1-00337

53.

Pryma

(2017). “Even my sister says I’m acting like a crazy to get a check”: Race, gender, and moral boundary-work in women’s claims of disabling chronic pain. Social Science & Medicine, 181, 66–73. https://doi.org/10.1016/j.socscimed.2017.03.048

54.

Quintner

(2020). Why are women with fibromyalgia so stigmatized? Pain Medicine, 21(5), 882–888. https://doi.org/10.1093/pm/pnz350

55.

Raja

S. N.

Carr

D. B.

Cohen

Finnerup

N. B.

Flor

Gibson

Keefe

F. J.

Mogil

J. S.

Ringkamp

Sluka

K. A.

Song

X.-J.

Stevens

Sullivan

M. D.

Tutelman

P. R.

Ushida

Vader

(2020). The revised international association for the study of pain definition of pain: Concepts, challenges, and compromises. Pain, 161, 1976–1982. https://doi.org/10.1097/j.pain.0000000000001939

56.

Rapley

(2014). Sampling strategies in qualitative research. In Flick

(Ed.), The SAGE handbook of qualitative data analysis (pp. 49–63). SAGE.

57.

Room

(2005). Stigma, social inequality and alcohol and drug use. Drug and Alcohol Review, 24(2), 143–155. https://doi.org/10.1080/09595230500102434

58.

Sinha

C. B.

Bakshi

Ross

Krishnamurti

(2019). Management of chronic pain in adults living with sickle cell disease in the era of the opioid epidemic: A qualitative study. JAMA Network Open, 2(5), Article e194410. https://doi.org/10.1001/jamanetworkopen.2019.4410

59.

Slade

S. C.

Molloy

Keating

J. L.

(2009). Stigma experienced by people with nonspecific chronic low back pain: A qualitative study. Pain Medicine, 10(1), 143–154. https://doi.org/10.1111/j.1526-4637.2008.00540.x

60.

Smith

A. A.

(2003). Intimacy and family relationships of women with chronic pain. Pain Management Nursing: Official Journal of the American Society of Pain Management Nurses, 4(3), 134–142. https://doi.org/10.1016/s1524-9042(03)00030-4

61.

Soklaridis

Cartmill

Cassidy

(2011). Biographical disruption of injured workers in chronic pain. Disability and Rehabilitation, 33(22–23), 2372–2380. https://doi.org/10.3109/09638288.2011.573056

62.

Special Advisory Committee on the Epidemic of Opioid Overdoses. (2020). Opioid-related harms in Canada. Public Health Agency of Canada. https://health-infobase.canada.ca/substance-related-harms/opioids

63.

Strauss

Fagerhaugh

Suczek

Wiener

(1982). The work of hospitalized patients. Social Science & Medicine, 16(9), 977–986. https://doi.org/10.1016/0277-9536(82)90366-5

64.

Strauss

A. L.

(1975). Chronic illness and the quality of life. Mosby.

65.

Suzuki

El-Haddad

(2017). A review: Fentanyl and non-pharmaceutical fentanyls. Drug and Alcohol Dependence, 171, 107–116. https://doi.org/10.1016/j.drugalcdep.2016.11.033

66.

Thompson

C. M.

Parsloe

(2019). “I don’t claim to be the world’s foremost expert, but. . . ”: How individuals “know” family members are not experiencing health issues as severely as they claim. Qualitative Health Research, 29(10), 1433–1446. https://doi.org/10.1177/1049732319827518

67.

Toye

Seers

Allcock

Briggs

Carr

Andrews

Barker

(2013). A meta-ethnography of patients’ experience of chronic non-malignant musculoskeletal pain. Health Services and Delivery Research, 1(12), 1–190. https://doi.org/10.3310/hsdr01120

68.

Treede

R.-D.

Rief

Barke

Aziz

Bennett

M. I.

Benoliel

Cohen

Evers

Finnerup

N. B.

First

M. B.

Giamberardino

M. A.

Kaasa

Kosek

Lavand’homme

Nicholas

Perrot

Scholz

Schug

Smith

B. H.

Wang

S.-J.

(2015). A classification of chronic pain for ICD-11. Pain, 156(6), 1003–1007. https://doi.org/10.1097/j.pain.0000000000000160

69.

Tsai

A. C.

Kiang

M. V.

Barnett

M. L.

Beletsky

Keyes

K. M.

McGinty

E. E.

Smith

L. R.

Strathdee

S. A.

Wakeman

S. E.

Venkataramani

A. S.

(2019). Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Medicine, 16(11), Article e1002969. https://doi.org/10.1371/journal.pmed.1002969

70.

Varpio

Ajjawi

Monrouxe

L. V.

O’Brien

B. C.

Rees

C. E.

(2017). Shedding the cobra effect: Problematising thematic emergence, triangulation, saturation and member checking. Medical Education, 51(1), 40–50. https://doi.org/10.1111/medu.13124

71.

Von Korff

Kolodny

Deyo

R. A.

Chou

. (2011). Long-term opioid therapy reconsidered. Annals of Internal Medicine, 155(5), 325–328. https://doi.org/10.1059/0003-4819-155-5-201109060-00011

72.

Waugh

O. C.

Byrne

D. G.

Nicholas

M. K.

(2014). Internalized stigma in people living with chronic pain. The Journal of Pain, 15(5), Article 550.e1–550.e10. https://doi.org/10.1016/j.jpain.2014.02.001

73.

Webster

Rice

Sud

(2020). A critical content analysis of media reporting on opioids: The social construction of an epidemic. Social Science & Medicine, 244, Article 112642. https://doi.org/10.1016/j.socscimed.2019.112642

74.

Werner

Malterud

(2003). It is hard work behaving as a credible patient: Encounters between women with chronic pain and their doctors. Social Science & Medicine, 57(8), 1409–1419. https://doi.org/10.1016/S0277-9536(02)00520-8

75.

Whittemore

Chase

S. K.

Mandle

C. L.

(2001). Validity in qualitative research. Qualitative Health Research, 11(4), 522–537.

76.

Zoorob

(2019). Fentanyl shock: The changing geography of overdose in the United States. International Journal of Drug Policy, 70, 40–46. https://doi.org/10.1016/j.drugpo.2019.04.010